GVOKE
Live / Applied — First extension granted (statement of use) (as of 17 Nov 2025)
What this means for you
Not registered yet, but its 19 Apr 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98509233
- Mark type
- Design + words
- Filed
- 19 Apr 2024
- Published for opposition
- 03 Dec 2024
- Attorney of record
- Tracy-Gene G. Durkin
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of diabetes and metabolic diseases; medical apparatus, namely, a drug delivery device prefilled with pharmaceutical products for the treatment of diabetes and metabolic diseases; pre-filled syringes and vials containing pharmaceutical preparations for the treatment of diabetes and metabolic diseases
Owner
- Xeris Pharmaceuticals, Inc., Chicago, IL, US
- Xeris Pharmaceuticals, Inc., Chicago, IL, US
Prior registrations
Prosecution history
- 18 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Nov 2025 — SOU EXTENSION 1 GRANTED
- 17 Nov 2025 — SOU EXTENSION 1 FILED
- 17 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 20 May 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 13 Apr 2025 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 16 Dec 2024 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 03 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Dec 2024 — PUBLISHED FOR OPPOSITION
- 27 Nov 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Nov 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Nov 2024 — ASSIGNED TO EXAMINER
- 06 Oct 2024 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 06 Oct 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 19 Apr 2024 — NEW APPLICATION ENTERED